Mini Review
Volume 8 Issue 6 - 2021
Physiopathological Considerations of Ischemic Heart Disease and its Risk Factors
Abel Muñoz Cedeño1* and Livan Hierrezuelo Fuentes2
15th Medicine Student, Faculty of Medicine “Enrique Cabrera”, University of Medical Sciences of Havana, Cuba
25th Dentistry Student, School of Dentistry “Raúl González Sánchez”, University of Medical Sciences of Havana, Cuba
*Corresponding Author: Abel Muñoz Cedeño, 5th Medicine Student, Teaching Assistant in Paediatry, Faculty of Medicine “Enrique Cabrera”, University of Medical Sciences of Havana, Santiago de Las Vegas, Boyeros, Havana, Cuba.
Received: March 30, 2021; Published: May 27, 2021




Abstract

Cardiovascular diseases, in its many variants and manifestations, account for the highest number of deaths in the world. Ischemic heart disease has a multifactorial origin, therefore, one risk factor must be considered in the context of the others. They are divided into two large groups: non-modifiable such as age, sex, family history and modifiable such as high blood pressure, atherosclerosis, dyslipidemia, smoking, diabetes, obesity and sedentary lifestyle. Expanding the study of the influence of each cardiovascular risk factor in the development of ischemic heart disease helps to reduce morbidity and mortality, and devise strategies to control the disease.

Keywords: Ischemic Heart Disease; Risk Factor; Atherosclerosis, Hypertension; Cardiovascular Diseases

References

  1. Vega Abascal J., et al. “Riesgo cardiovascular, una herramienta útil para la prevención de las enfermedades cardiovasculares”. Revista Cubana de Medicina General Integral1 (2012): 91-97.
  2. Erhardt L. “Rationales for multiple risk interventions: the need to move from theory to practice”. Vascular Health and Risk Management6 (2009): 985-997.
  3. Guías de práctica clínica para el tratamiento de la hipertensión arterial”. Revista Española de Cardiología9 (2007): 968-994.
  4. Vega Abascal V., et al. “Riesgo cardiovascular, una herramienta útil para la prevención de las enfermedades cardiovasculares”. Revista Española de Cardiología10 (2012).
  5. Molinero LM. “Modelos de riesgo cardiovascular”. Estudio Framingham. Proyecto SCORE (2009).
  6. Florenzano F. “Riesgo cardiovascular global y diagnóstico por imágenes de la ateroesclerosis”. Med Clin Condes 19.1 (2008): 14-20.
  7. Rodríguez Carrasco B., et al. “Influencia de la dieta rica en antioxidantes en los pacientes portadores de cardiopatía isquémica”. Revista Habanera de Ciencias Médicas 1 (2012).
  8. Teo K., et al. “Prevalence of a healthy lifestyle among individuals with cardiovascular disease in high, middle, and low-income countries: the Prospective Urban Rural Epidemiology (PURE) study”. The Journal of the American Medical Association 309 (2013): 1613-1621.
  9. Lieb W. “Genetic predisposition to higher blood pressure increases coronary artery disease risk”. Hypertension 61 (2013): 995-1001.
  10. Daviglus M. “Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States”. The Journal of the American Medical Association 308 (2012): 1775-1784.
  11. O’Gara PT., et al. “2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines”. Circulation 127 (2013): 529-555.
  12. Van Kranenburg M., et al. “Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients”. JACC Cardiovasc Imaging 7 (2014): 930-939.
  13. Hervas A., et al. “Infusión intracoronaria de tioflavina-S para el estudio de la obstrucción microvascular en un modelo de infarto de miocardio”. Revista Española de Cardiología 68 (2015): 928-934.
  14. Varon J and Marik PE. “Clinical review: the management of hypertensive crises”. Critical Care 7 (2003): 374-384.
  15. Marik PE and Rivera R. “Hypertensive emergencies: an update”. Critical Care 17 (2012): 569-580.
  16. Vadhera RB and Simon M. “Hypertensive emergencies in pregnancy”. Clinical Obstetrics and Gynecology 57 (2014): 797-805.
  17. Tulman DB., et al. “Advances in management of acute hipertensión: A concise review”. Discovery Medicine 13 (2012): 375-383.
  18. Padilla Ramos A and Varon J. “Current and newer agents for hypertensive emergencies”. Current Hypertension Reports 16 (2014): 450.
  19. McMurray JJV., et al. “ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012.The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC”. European Heart Journal 33 (2012): 1787-1847.
  20. Yancy CW., et al. “2013 ACCF/AHA Guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines”. Circulation 128 (2013): 1-126.
  21. Patel SR and Piña IL. “From acute decompensated to chronic heart failure”. The American Journal of Cardiology 114 (2014): 1923-1929.
  22. Borlaug BA and Paulus JW. “Heart failure with preserved ejection fraction: Pathophysiology, diagnosis and treatment”. European Heart Journal 32 (2012): 670-679.
  23. Guglin M. “Key role of congestion in natural history of heart failure”. International Journal of General Medicine 4 (2011): 585-591.
  24. Borlaug BA and Redfield MM. “Diastolic and systolic failure are distinct phenotypes within the heart failure spectrum”. Circulation 123 (2014): 2006-2014.
  25. De Keulenaer GW and Brutsaert DL. “Systolic and diastolic heart failure are overlapping phenotypes within the heart failure spectrum”. Circulation 123 (2012): 1996-2005.
  26. Ponikowski P and Jankowska EA. “Patogenia y presentación clínica de la insuficiencia cardiaca aguda”. Revista Española de Cardiología 68 (2015): 331-337.
  27. Kazori A and Elkayam U. “Cardiorenal interactions in acute decompensated heart failure: Contemporary concepts facing emerging controversies”. Journal of Cardiac Failure 20 (2014): 1004-1011.
  28. Shah AM and Pfeffer MA. “Heart failure with preserved ejection fraction: A forest of variety of trees”. European Heart Journal 35 (2014): 3410-3412.
  29. Marzilli M., et al. “Obstructive coronary atherosclerosis and ischemic heart disease: An elusive link!” Journal of the American College of Cardiology 60 (2012): 951.
  30. Pepine CJ and Douglas PS. “Rethinking stable ischemic heart disease: Is this the beginning of a new era?” Journal of the American College of Cardiology 60 (2012): 957.
Citation: Abel Muñoz Cedeño and Livan Hierrezuelo Fuentes. “Physiopathological Considerations of Ischemic Heart Disease and its Risk Factors”. EC Cardiology 8.6 (2021): 33-39.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


September Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the September issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before September 28, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk